NY Times

SEPTEMBER 11, 2021

At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.

Nurses 122

Nurses Drugs Regulation 122

ECRG Media's Clinical Research Podcast

SEPTEMBER 11, 2021

Why You Should Get Your Start At a Small Biotech Company (Part 3) Do you want to win a free career consultation? Comment under the full interview video released last week with Tiffany and comment for your chance to win. Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resu

Clinical Research 52

Clinical Research Research Production 52

Scienmag

SEPTEMBER 11, 2021

Adenomyosis – an abnormal tissue growth into the muscular wall of the uterus that causes painful cramps and heavy or prolonged menstrual bleeding – is more common than generally appreciated, a review of the literature by gynecologists at UT Southwestern Medical Center revealed. Credit: UT Southwestern Medical Center Adenomyosis – an abnormal tissue growth into […].

Medicine 52

Medicine 52

ECRG Media's Clinical Research Podcast

SEPTEMBER 11, 2021

Why You Should Get Your Start At a Small Biotech Company (Part 3). Do you want to win a free career consultation? Comment under the full interview video released last week with Tiffany and comment for your chance to win. Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Res

Clinical Research 52

Clinical Research Research Production 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

The Pharma Data

SEPTEMBER 11, 2021

– Designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with preserved ejection fraction. The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Jardiance ® (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer

Medicine 52

Medicine Insulin FDA Approval Trials 52

BioTech 365

SEPTEMBER 11, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientists debate promise, peril of tweaking wild genomes.In the movie Jurassic Park, reconstructing and tweaking genetic material makes it possible to bring dinosaurs back to life.

Scientist 40

Scientist Genome Genomics Genetics 40

Drug Patent Watch

SEPTEMBER 11, 2021

This chart shows the drugs with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Japan? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs 59

The Pharma Data

SEPTEMBER 11, 2021

Bristol Myers Squibb today announced findings from a global real-world evidence study that the risk of mortality increases with worse New York Heart Association functional class (NYHA class) for patients with obstructive hypertrophic cardiomyopathy (obstructive HCM). While other studies have documented this association in HCM, this study represents one of the largest, multi-centered studies that specifically focuses on the obstructive HCM patient population.

Research 52

Research Medicine Protein Development 52

Drug Patent Watch

SEPTEMBER 11, 2021

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Sweden. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

The Pharma Data

SEPTEMBER 11, 2021

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries to discover therapeutic antibodies against multiple targets provided by Boehringer Ingelheim.

Antibody 52

Antibody DNA Containment Manufacturing 52

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

The Pharma Data

SEPTEMBER 11, 2021

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for empagliflozin as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced. This follows results from the Phase III EMPEROR-Preserved trial which investigated the composite endpoint of cardiovascular death or hospitalization for heart failure in patients with HFpEF. 1.

Trials 52

Trials Clinical Trials Clinical Trials Cardiology 52